Our aim is to support the National Strategy for the Quality Use of Medicines.

The goal of the strategy is to make the best possible use of medicines to improve health outcomes for all Australians. We support this goal by providing free access to high quality, up to date information about medicines that are approved for use in Australia.

Pharmaceutical companies are required by government to keep the Product Information (PI) up to date as new information about medicines becomes available. This web site contains the most up to date version of Consumer Medicine Information (CMI) and PI that are available in Australia, as the web site is updated within hours of the release of the updated CMI and PI from the company

Updated products

Product name Type Date released
Jardiamet PI 07 Apr 2020
Jardiamet CMI 07 Apr 2020
Ofev CMI 07 Apr 2020
Camptosar CMI 07 Apr 2020
Zelboraf CMI 07 Apr 2020

New products

Product name Type Date released
Methoblastin PFS CMI 07 Apr 2020
DBL Oxaliplatin CMI 07 Apr 2020
DBL Oxaliplatin PI 06 Apr 2020
Fulphila CMI 03 Apr 2020
APO-Latanoprost CMI 02 Apr 2020